| Ytd | -63.25% | |
| 1y | -86.95% |
| Open | 0.99 | Prev Close | 0.99 | Low | 0.98 | High | 0.99 | Mkt Cap | 1.02M |
| Vol | 76.78K | Avg Vol | 5.96M | EPS | -9.77 | P/E | -0.10 | Forward P/E | -11.88 |
| Beta | 0.89 | Short Ratio | 0.09 | Inst. Own | 0.95% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 2.35 | 200-d Avg | 3.08 | 1yr Est | 256.00 |
Gainers Zhengye Biotechnology (NASDAQ:ZYBT) stock increased by 107.0% to $2.65 during Wednesday'
Gainers Bluejay Diagnostics (NASDAQ:BJDX) shares moved upwards by 43.0% to $1.43 during Wednesday&#
Arista Networks Inc (ANET) reported strong Q2 results, with revenue of $3.04B, up 37.7% YoY. Shares
Gainers Bluejay Diagnostics (NASDAQ:BJDX) stock moved upwards by 42.0% to $1.42 during Tuesday'
750 Patients Enrolled Ahead of Plan in Pivotal Study Evaluating Symphony™ IL-6 for Early Assessment
Gainers Advanced Biomed (NASDAQ:ADVB) shares rose 24.1% to $6.24 during Monday's pre-market ses
Gainers iTonic Holdings (NASDAQ:ITOC) stock increased by 8.1% to $0.3 during Friday's after-mar
Shares of Aehr Test Systems (NASDAQ: AEHR) jumped 29.6% to $93.30 in pre-market trading. Aehr Test
Gainers NextCure (NASDAQ:NXTC) shares rose 305.5% to $8.84 during Tuesday's pre-market session.
Vision Marine Technologies Inc (NASDAQ: VMAR) gained 60.3% to $2.26 in pre-market trading after repo
Gainers Pulsenmore (NASDAQ:PLSM) shares increased by 171.2% to $10.47 during Monday's pre-marke
Gainers Virax Biolabs Group (NASDAQ:VRAX) stock increased by 134.0% to $7.44 during Thursday's
Stocks moving: RPGL +54.5%, EDBL +42.5%, SDOT +27.4%, BJDX +24.6%, AP +19.9%, SUNE +18%, ALNY +15.3%
Gainers Crinetics Pharmaceuticals (NASDAQ:CRNX) shares moved upwards by 98.7% to $83.53 during Tues
Gainers Crinetics Pharmaceuticals (NASDAQ:CRNX) stock increased by 98.9% to $83.59 during Tuesday&#
Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) rose in pre-market trading after being acquired by Vert
Gainers Vicore Pharma Holding (NASDAQ:VCRE) stock rose 149.8% to $42.47 during Monday's after-m
Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 284.8% to $11.39 during Monday
$8.5 million upfront with up to approximately $15.2 million of potential additional gross proceeds u
Bluejay Diagnostics, Inc. (NASDAQ:BJDX) shares are trading lower on Wednesday. On Tuesday, the compa
$8.5 million upfront with up to approximately $15.1 million of potential additional gross proceeds u
HPE: 30% | Hewlett Packard Enterprise shares are trading higher after the company reported better-th
ACTON, Mass. and CARLSBAD, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (“Blu
ACTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (“Bluejay” or the “Company”
Bluejay Diagnostics (NASDAQ: BJDX - Get Free Report) and STERIS (NYSE: STE - Get Free Report) are bo
Fresenius Medical Care AG and Co. KGaA (NYSE: FMS - Get Free Report) and Bluejay Diagnostics (NASDAQ
ACTON, Mass., April 07, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (“Bluejay” or the “Compan
Coloplast A/S (OTCMKTS:CLPBY - Get Free Report) and Bluejay Diagnostics (NASDAQ: BJDX - Get Free Rep
New clinical data from the SYMON-I study to evaluate IL-6 and organ dysfunction in sepsis patients t
NEWPORT BEACH, Calif., March 11, 2026 (GLOBE NEWSWIRE) -- NorthStrive Fund II LP (“NorthStrive Fund”
ACTON, Mass., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics (NASDAQ: BJDX) today announced t
ACTON, Mass., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics (NASDAQ: BJDX) today announced t
Bluejay Diagnostics, Inc. (NASDAQ: BJDX - Get Free Report) traded up 0.1% on Wednesday. The company
ACTON, Mass., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”
Bluejay Diagnostics (NASDAQ: BJDX - Get Free Report) and CVRx (NASDAQ: CVRX - Get Free Report) are b
Shares of Bluejay Diagnostics, Inc. (NASDAQ: BJDX - Get Free Report) were down 6.2% on Friday. The s
ACTON, Mass., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”
ACTON, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”